Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Santoro

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancers|November 7, 2017
Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer TherapySeraina Faes, Tania Santoro, Nicolas Demartines, et al.
International Journal of Molecular Sciences|August 1, 2018
mTOR and Tumor CachexiaAdrian P Duval, Cheryl Jeanneret, Tania Santoro, et al.
Biochemical and Biophysical Research Communications|April 15, 2019
Rebound pathway overactivation by cancer cells following discontinuation of PI3K or mTOR inhibition promotes cancer cell growthSeraina Faes, Tania Santoro, Laetitia Troquier, et al.
Oncotarget|November 17, 2016
Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapiesSeraina Faes, Emilie Uldry, Anne Planche, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 24, 2020
Targeting connexin37 alters angiogenesis and arteriovenous differentiation in the developing mouse retinaLauriane Hamard, Tania Santoro, Florent Allagnat, et al.
Journal of the American Heart Association|April 5, 2019
Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated HypertensionLoïc Le Gal, Maxime Pellegrin, Tania Santoro, et al.
International Journal of Molecular Sciences|March 25, 2022
Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor GrowthKarthik Sathiyanadan, Florian Alonso, Sonia Domingos-Pereira, et al.
International Journal of Molecular Sciences|March 14, 2026
Correction: Sathiyanadan et al. Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 2930Karthik Sathiyanadan, Florian Alonso, Sonia Domingos-Pereira, et al.
Oncotarget|May 7, 2016
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitorsSeraina Faes, Anne Planche, Emilie Uldry, et al.
Molecular Cancer|December 7, 2016
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitorsSeraina Faes, Adrian P Duval, Anne Planche, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancers|November 7, 2017
Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer TherapySeraina Faes, Tania Santoro, Nicolas Demartines, et al.
International Journal of Molecular Sciences|August 1, 2018
mTOR and Tumor CachexiaAdrian P Duval, Cheryl Jeanneret, Tania Santoro, et al.
Biochemical and Biophysical Research Communications|April 15, 2019
Rebound pathway overactivation by cancer cells following discontinuation of PI3K or mTOR inhibition promotes cancer cell growthSeraina Faes, Tania Santoro, Laetitia Troquier, et al.
Oncotarget|November 17, 2016
Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapiesSeraina Faes, Emilie Uldry, Anne Planche, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 24, 2020
Targeting connexin37 alters angiogenesis and arteriovenous differentiation in the developing mouse retinaLauriane Hamard, Tania Santoro, Florent Allagnat, et al.
Journal of the American Heart Association|April 5, 2019
Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated HypertensionLoïc Le Gal, Maxime Pellegrin, Tania Santoro, et al.
International Journal of Molecular Sciences|March 25, 2022
Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor GrowthKarthik Sathiyanadan, Florian Alonso, Sonia Domingos-Pereira, et al.
International Journal of Molecular Sciences|March 14, 2026
Correction: Sathiyanadan et al. Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 2930Karthik Sathiyanadan, Florian Alonso, Sonia Domingos-Pereira, et al.
Oncotarget|May 7, 2016
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitorsSeraina Faes, Anne Planche, Emilie Uldry, et al.
Molecular Cancer|December 7, 2016
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitorsSeraina Faes, Adrian P Duval, Anne Planche, et al.
Pageof 2